Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study.
Stahl A, Bründer MC, Lagrèze WA, Molnár FE, Barth T, Eter N, Guthoff R, Krohne TU, Pfeil JM; CARE-ROP Study Group. Stahl A, et al. Among authors: brunder mc. Acta Ophthalmol. 2022 Feb;100(1):e91-e99. doi: 10.1111/aos.14852. Epub 2021 Mar 19. Acta Ophthalmol. 2022. PMID: 33742551 Free PMC article. Clinical Trial.
Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity.
Pivodic A, Johansson H, Smith LEH, Hård AL, Löfqvist C, Yoder BA, Hartnett ME, Wu C, Bründer MC, Lagrèze WA, Stahl A, Al-Hawasi A, Larsson E, Lundgren P, Gränse L, Sunnqvist B, Tornqvist K, Wallin A, Holmström G, Albertsson-Wikland K, Nilsson S, Hellström A. Pivodic A, et al. Among authors: brunder mc. Br J Ophthalmol. 2022 Nov;106(11):1573-1580. doi: 10.1136/bjophthalmol-2020-318719. Epub 2021 May 12. Br J Ophthalmol. 2022. PMID: 33980506 Free PMC article.
Anti-drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease.
Busch M, Pfeil JM, Dähmcke M, Brauckmann T, Großjohann R, Chisci V, Hunfeld E, Eilts S, Omran W, Morawiec-Kisiel E, Schulz D, Paul S, Tayar A, Bründer MC, Grundel B, Küstner M, Stahl A. Busch M, et al. Among authors: brunder mc. Acta Ophthalmol. 2022 Dec;100(8):903-910. doi: 10.1111/aos.15124. Epub 2022 Feb 28. Acta Ophthalmol. 2022. PMID: 35225432 Free article.
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.
Eilts SK, Pfeil JM, Poschkamp B, Krohne TU, Eter N, Barth T, Guthoff R, Lagrèze W, Grundel M, Bründer MC, Busch M, Kalpathy-Cramer J, Chiang MF, Chan RVP, Coyner AS, Ostmo S, Campbell JP, Stahl A; Comparing Alternative Ranibizumab Dosages for Safety and Efficacy in Retinopathy of Prematurity (CARE-ROP) Study Group. Eilts SK, et al. Among authors: brunder mc. JAMA Netw Open. 2023 Jan 3;6(1):e2251512. doi: 10.1001/jamanetworkopen.2022.51512. JAMA Netw Open. 2023. PMID: 36656578 Free PMC article. Clinical Trial.
[Use of artificial intelligence in screening for diabetic retinopathy at a tertiary diabetes center].
Paul S, Tayar A, Morawiec-Kisiel E, Bohl B, Großjohann R, Hunfeld E, Busch M, Pfeil JM, Dähmcke M, Brauckmann T, Eilts S, Bründer MC, Grundel M, Grundel B, Tost F, Kuhn J, Reindel J, Kerner W, Stahl A. Paul S, et al. Among authors: brunder mc. Ophthalmologie. 2022 Jul;119(7):705-713. doi: 10.1007/s00347-021-01556-5. Epub 2022 Jan 26. Ophthalmologie. 2022. PMID: 35080640 German.
Circulating MicroRNAs as Biomarker for Vessel-Associated Retinal Diseases.
Dähmcke M, Busch M, Pfeil JM, Brauckmann T, Schulz D, Omran W, Morawiec-Kisiel E, Wähler F, Paul S, Tayar A, Bründer MC, Grundel B, Stahl A. Dähmcke M, et al. Among authors: brunder mc. Ophthalmologica. 2023;246(3-4):227-237. doi: 10.1159/000533481. Epub 2023 Aug 9. Ophthalmologica. 2023. PMID: 37721532 Free article.
17 results